CDC Study Finds 112 Pregnant Women and 13 Newborns Sickened by Measles
Measles is spreading into a population it barely touched for decades: pregnant women and their babies. A new CDC study counts 112 infected mothers and at least 13 newborns in two years, with nearly a quarter of the women hospitalized. Doctors say the findings land as the U.S. nears losing its measles elimination status.
- Original source: inquirer.com.
- The source published it on Nov 16, 2026 at 11:47 PM.
- No second outlet has reported it yet. Treat it as a single-source claim.
More than 100 pregnant women and at least 13 newborns in the United States have caught measles over the past two years, Centers for Disease Control and Prevention scientists reported Monday. The preliminary analysis, published in the New England Journal of Medicine Evidence, is the first to document how infections during pregnancy have climbed alongside the virus's national resurgence.
The toll is heavy. Of the 112 pregnant women infected, nearly one-quarter were hospitalized for complications unrelated to labor, including pneumonia and respiratory failure. One landed in intensive care. Some delivered prematurely, and two lost their pregnancies. Most of the women were unvaccinated. Pregnant women are 10 times as likely to die from measles, the study notes, because their immune systems are temporarily weakened.
The timing is grim. The findings arrive shortly before the U.S. is expected to lose its measles elimination status, and as the federal health department faces criticism over its measles response. Health Secretary Robert F. Kennedy Jr. has repeatedly cast doubt on the safety and efficacy of the MMR shot, floated scaling back childhood vaccine recommendations, and cut funding for vaccine research. This year, state health officials have reported more than 5,000 measles cases and 10 deaths nationwide.
Outside experts flagged it as unusual that CDC scientists published in an outside journal rather than the agency's own. The Washington Post reported that this fall the CDC blocked its scientists from issuing an urgent alert on measles in pregnancy, and the agency has publicly challenged two measles deaths reported by Pennsylvania officials. A CDC spokesperson, Grace Davis Jamison, said scientists may publish externally and chose to here because it was the fastest way to get the information out. David Kimberlin of the University of Alabama at Birmingham put it plainly: in normal times this would have run in the CDC's journal, but these are not normal times.
Researchers are now racing to map what happens to babies exposed in the womb. Michelle Barton-Forbes, a pediatric infectious disease doctor who worked at the center of a large Canadian outbreak last year, documented some of the first recent North American cases of congenital measles. She identified a neurological complication called subacute sclerosing panencephalitis, which can strike a child up to a decade after infection and is almost always fatal. While it affects roughly 1 in 100,000 of those infected overall, some researchers estimate one in 158 infants develop it, because their immune systems can't stop the virus before it reaches the brain.
Barton-Forbes plans to track her congenital measles patients for SSPE and for other infections tied to immune amnesia, where measles erases the immune system's memory and leaves patients vulnerable to other illnesses. Michael Osterholm of the University of Minnesota summed up the shift: this is much worse than we thought. Adam Ratner of the American Academy of Pediatrics added that there are a lot of holes in what doctors know, and that losing elimination status means rare outcomes start showing up more often.
TopicsCDC · Robert F. Kennedy Jr. · Michael Osterholm · Adam Ratner · Michelle Barton-Forbes · David Kimberlin · New England Journal of Medicine Evidence · Department of Health and Human Services
Source: inquirer.com
Written by AI from verified reporting.
More stories
- Health & science theguardian.com 0 viewsEuropean Pesticides Named in 1,605 Brazil Poisoning Reports
- Health & science theepochtimes.com 0 viewsFDA Refuses to Approve Akeso-Summit Lung Cancer Drug After Survival Miss
- Health & science targetedonc.com 0 viewsFDA clears Biocon's Perjeta biosimilar, but US shelves wait until 2028
- Health & science healthandme.com 0 viewsEurope approves Revolution Medicines' RAS-blocking pancreatic cancer pill

